异动解读 | HCA控股盘中大涨5.04%,获多家投行上调评级目标价

异动解读
28 Jan

美国医疗服务公司HCA控股(HCA.US)今日盘中大涨5.04%,引起市场高度关注。

投行研报显示,多家机构上调了对HCA控股的评级和目标股价预期,这成为推动该股上涨的主要原因。加拿大皇家银行将HCA控股的目标价从405美元上调至384美元;巴克莱则维持该股"增持"评级,但将目标价从392美元调整至366美元。

在投资者看来,知名投行上调评级和目标价,反映了市场对HCA控股未来增长前景的积极预期。HCA控股是全美最大的非营利性医疗服务公司,在医疗服务行业占据领先地位,其业务表现及盈利能力获得资本市场认可。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10